Ke Peng

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Venues

Cell research

Signal transduction and targeted therapy

Cell discovery

PLoS pathogens

Wuhan Institute of Virology Chinese Academy of Sciences

Wageningen University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Wuhan Institute of Virology Chinese Academy of Sciences Oct 08 2016

China

Principle Investigator, Professor

Heidelberg University, Medical Faculty Apr 02 2012 - Sep 30 2016

Germany

Postdoctoral researcher :: Department of Infectious Diseases, Virology

Education History

Wageningen University Jan 16 2008 - Mar 20 2012

Netherlands

PHD :: Laboratory of Virology

Publications

Zhenqiong Guan, Huiling Li, Chongtao Zhang, Ziyan Huang, Meidi Ye, Yulan Zhang, Shufen Li, Ke Peng
RVFV virulence factor NSs triggers the mitochondrial MCL-1-BAK axis to activate pathogenic NLRP3 pyroptosis. PLoS pathogens 20 (8) (2024)
Shufen Li, Yulan Zhang, Zhenqiong Guan, Meidi Ye, Huiling Li, Miaomiao You, Zhenxing Zhou, Chongtao Zhang, Fan Zhang, Ben Lu, Peng Zhou, Ke Peng
SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses. Cell research 33 (3) (2023)
Shufen Li, Yulan Zhang, Zhenqiong Guan, Meidi Ye, Huiling Li, Miaomiao You, Zhenxing Zhou, Chongtao Zhang, Fan Zhang, Ben Lu, Peng Zhou, Ke Peng
SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses. Cell research 33 (3) (2023)
Shufen Li, Yulan Zhang, Zhenqiong Guan, Meidi Ye, Huiling Li, Miaomiao You, Zhenxing Zhou, Chongtao Zhang, Fan Zhang, Ben Lu, Peng Zhou, Ke Peng
SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses. Cell research (2023)
Shufen Li, Yulan Zhang, Zhenqiong Guan, Meidi Ye, Huiling Li, Miaomiao You, Zhenxing Zhou, Chongtao Zhang, Fan Zhang, Ben Lu, Peng Zhou, Ke Peng
SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses. Cell research 33 (3) (2023)
Xiangtao Zhu, Zihan Guan, Yujie Fang, Yulan Zhang, Zhenqiong Guan, Shufen Li, Ke Peng
Rift Valley Fever Virus Nucleoprotein Triggers Autophagy to Dampen Antiviral Innate Immune Responses. Journal of virology (2023)
Shufen Li, Yulan Zhang, Zhenqiong Guan, Meidi Ye, Huiling Li, Miaomiao You, Zhenxing Zhou, Chongtao Zhang, Fan Zhang, Ben Lu, Peng Zhou, Ke Peng
SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses. Cell research (2023)
Lei-Ke Zhang, Xue-Fang Peng, Qingxing Wang, Jin Li, Shouming Lv, Shuo Han, Lingyu Zhang, Heng Ding, Cong-Yi Wang, Gengfu Xiao, Xuguang Du, Ke Peng, Hao Li, Wei Liu
CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus. Science advances 9 (31) (2023)
Shouheng Jin, Xing He, Ling Ma, Zhen Zhuang, Yiliang Wang, Meng Lin, Sihui Cai, Lu Wei, Zheyu Wang, Zhiyao Zhao, Yaoxing Wu, Lin Sun, Chun Wei Li, Weihong Xie, Yong Zhao, Zhou Songyang, Ke Peng, Jin-Cun Zhao, Jun Cui
Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy. Nature communications 13 (1) (2022)
Xu-Rui Shen, Rong Geng, Qian Li, Ying Chen, Shu-Fen Li, Qi Wang, Juan Min, Yong Yang, Bei Li, Ren-Di Jiang, Xi Wang, Xiao-Shuang Zheng, Yan Zhu, Jing-Kun Jia, Xing-Lou Yang, Mei-Qin Liu, Qian-Chun Gong, Yu-Lan Zhang, Zhen-Qiong Guan, Hui-Ling Li, Zhen-Hua Zheng, Zheng-Li Shi, Hui-Lan Zhang, Ke Peng, Peng Zhou
ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal transduction and targeted therapy 7 (1) (2022)
Zhiwei Sui, Xinhua Dai, Qing-Bin Lu, Yulan Zhang, Min Huang, Shufen Li, Tao Peng, Jie Xie, Yongzhuo Zhang, Chunchen Wu, Jianbo Xia, Lianhua Dong, Jiayi Yang, Wenfeng Huang, Siyuan Liu, Ziquan Wang, Ke Li, Qingfang Yang, Xi Zhou, Ying Wu, Wei Liu, Xiang Fang, Ke Peng
Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection. Signal transduction and targeted therapy 6 (1) (2021)
Yujie Fang, Ke Peng
Regulation of innate immune responses by cell death-associated caspases during virus infection. The FEBS journal (2021)
Hao Li, Xia-Ming Jiang, Ning Cui, Chun Yuan, Shao-Fei Zhang, Qing-Bin Lu, Zhen-Dong Yang, Qin-Lin Xin, Ya-Bin Song, Xiao-Ai Zhang, Hai-Zhou Liu, Juan Du, Xue-Juan Fan, Lan Yuan, Yi-Mei Yuan, Zhen Wang, Juan Wang, Lan Zhang, Dong-Na Zhang, Zhi-Bo Wang, Ke Dai, Jie-Ying Bai, Zhao-Nian Hao, Hang Fan, Li-Qun Fang, Gengfu Xiao, Yang Yang, Ke Peng, Hong-Quan Wang, Jian-Xiong Li, Lei-Ke Zhang, Wei Liu
Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome. Signal transduction and targeted therapy 6 (1) (2021)
Yuanling Yu, Meiyu Wang, Xiaoai Zhang, Shufen Li, Qingbin Lu, Haolong Zeng, Hongyan Hou, Hao Li, Mengyi Zhang, Fei Jiang, Jiajing Wu, Ruxia Ding, Zehua Zhou, Min Liu, Weixue Si, Tao Zhu, Hangwen Li, Jie Ma, Yuanyuan Gu, Guangbiao She, Xiaokun Li, Yulan Zhang, Ke Peng, Weijin Huang, Wei Liu, You-Chun Wang
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients. Signal transduction and targeted therapy 6 (1) (2021)
Lei-Ke Zhang, Yuan Sun, Haolong Zeng, Qingxing Wang, Xiaming Jiang, Wei-Juan Shang, Yan Wu, Shufen Li, Yu-Lan Zhang, Zhao-Nian Hao, Hongbo Chen, Runming Jin, Wei Liu, Hao Li, Ke Peng, Gengfu Xiao
Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell discovery 7 (1) (2021)
Min Huang, Qing-Bin Lu, Han Zhao, Yulan Zhang, Zhiwei Sui, Li-Qun Fang, Di Liu, Xiulian Sun, Ke Peng, Wei Liu, Wuxiang Guan
Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019. Cell discovery 6 (2020)
Shufen Li, Yulan Zhang, Zhenqiong Guan, Huiling Li, Meidi Ye, Xi Chen, Jun Shen, Yiwu Zhou, Zheng-Li Shi, Peng Zhou, Ke Peng
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal transduction and targeted therapy 5 (1) (2020)
Min Huang, Qing-Bin Lu, Han Zhao, Yulan Zhang, Zhiwei Sui, Li-Qun Fang, Di Liu, Xiulian Sun, Ke Peng, Wei Liu, Wuxiang Guan
Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019. Cell discovery 6 (1) (2020)
Lei-Ke Zhang, Yuan Sun, Haolong Zeng, Qingxing Wang, Xiaming Jiang, Wei-Juan Shang, Yan Wu, Shufen Li, Yu-Lan Zhang, Zhao-Nian Hao, Hongbo Chen, Runming Jin, Wei Liu, Hao Li, Ke Peng, Gengfu Xiao
Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell discovery 6 (1) (2020)
Mariia Novikova, Yulan Zhang, Eric O Freed, Ke Peng
Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle. Virologica Sinica 34 (2) (2019)
Hao Li, Lei-Ke Zhang, Shu-Fen Li, Shao-Fei Zhang, Wei-Wei Wan, Yu-Lan Zhang, Qi-Lin Xin, Ke Dai, Yuan-Yuan Hu, Zhi-Bo Wang, Xiang-Tao Zhu, Yu-Jie Fang, Ning Cui, Pan-He Zhang, Chun Yuan, Qing-Bin Lu, Jie-Ying Bai, Fei Deng, Geng-Fu Xiao, Wei Liu, Ke Peng
Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell research 29 (9) (2019)

Ke Peng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ke Peng